The first cannabis pharmaceutical for sleep has arrived. CannRX, a cannabis pharmaceutical company, has recently aligned with accelerator iCAN: Israel-Cannabis to launch a new cannabis-based sleep aid. The construction will be called ican.sleep, and it will be made from an extract of the real herb.
Instead of taking a pill, this sleep aid comes in the form of a spray. The spray contains a unique blend of cannabinoids that are designed to work in harmony to help you sleep.
This sleep aid comes at a time when a wave of new cannabis-based dietary products and pharmaceuticals are hitting the markets.
Recently, another pharmaceutical company, Cannabis Science, Inc. announced the development of a pain patch for fibromyalgia and diabetic neuropathy. A new epilepsy drug, Epidiolex by GW Pharmaceuticals, was successful in recent clinical trials.
Now, the partnership between CannRX and iCAN: Israel-Cannabis has added yet another valuable product to the budding cannabis neutraceutical industry. The team opted for a spray since similar available products were oral only and more difficult to dose and control.
The two companies hope to sell this product on a global scale later this year, pending patent trials. The hope is that the sleep aid will pave a way into the U.S. market.
Israel has been taking the global lead in medical cannabis research. Local researchers made breakthrough discoveries about the herb back in the 1960s when chemist Dr. Raphael Mechoualm first discovered tetrahydrocannabinol (THC), the primary psychoactive in the plant.
In the time since, Mechoulam and his team have made numerous discoveries about the healing potential of cannabis. Unlike in the United States, however, cannabis research in Israel leans heavily to the pharmaceutical and medical side of the equation.
Every other Friday we giveaway 1,000 Free quality glass pipes. In order to get your hands on one you simply need to click the following link: Enter To Win A Free Glass Pipe!